Lidocaine or magnesium sulfate to keep blood pressure steady after infertility surgery
Compares lidocaine and magnesium sulfate in women having infertility surgery.
Key facts
- Who runs it
- Zagazig University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Lidocaine vs Magnesium Sulfate for Hemodynamic Stability During Emergence in Infertility-Related Laparoscopic Surgery"
- Status
- Not yet recruiting
- People taking part
- 69 people, planned
- Started
- 2 Jan 2026
- Planned end
- 2 Jul 2026
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Lidocaine (drug)
- Normal Saline (Intravenous)
- magnesium sulfate
- Record updated
- 22 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 21 to 40 who are having a planned keyhole (laparoscopic) surgery related to infertility under general anesthesia. It compares lidocaine, magnesium sulfate and salt water for keeping blood pressure and heart rate steady while waking up.
- Age
- 21 to 40 years
- Sex
- Women only
- Disease stage
- Planned infertility-related laparoscopic gynecologic surgery under general anesthesia (for example diagnostic laparoscopy, ovarian cyst removal, release of scar tissue). Anesthesia is expected to last less than 2 hours. General health ASA class I or II (healthy or mild illness only). Body mass index (BMI) between 18.5 and 29 kg/m².
- Earlier treatment
- People who use pain medicines long-term cannot join.
Main reasons for not taking part
- Allergy to lidocaine or magnesium sulfate, or a reason they cannot be used
- Serious heart, kidney or liver disease in the past
- Long-term pain medicine use or past drug dependence
- Myasthenia gravis (a muscle weakness disease)
- Pregnancy or a positive blood pregnancy test (β-hCG)
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Female patients aged 21 to 40 years
- Body mass index (BMI) between 18.5 and 29 kg/m²
- American Society of Anesthesiologists (ASA) physical status I or II
- Scheduled for elective infertility-related laparoscopic gynecologic surgery (e.g., diagnostic laparoscopy, ovarian cystectomy, adhesiolysis) under general anesthesia
- Expected duration of anesthesia less than 2 hours
- Ability to provide written informed consent
Who cannot take part
- History of significant cardiac, renal, or hepatic disease
- Chronic use of analgesics or history of drug dependence
- History of myasthenia gravis
- Known allergy or contraindication to lidocaine or magnesium sulfate
- Pregnancy or positive serum β-hCG test
- -
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 21 and 40 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is being conducted to compare two medications, intravenous lidocaine and intravenous magnesium sulfate, and their ability to keep blood pressure and heart rate stable during the period of waking up from general anesthesia in infertility-related laparoscopic gynecologic surgeries.
Read full original descriptionShow less
Laparoscopic gynecologic procedures can cause changes in heart rate and blood pressure, especially during emergence from anesthesia, and these changes may affect patient safety.
In this randomized, double-blind clinical trial, women scheduled for elective infertility-related laparoscopic surgery will be assigned to one of three groups: lidocaine, magnesium sulfate, or a control group. The study will evaluate mean arterial pressure (primary outcome), heart rate, pain scores, sedation level, nausea and vomiting, and any side effects during and after surgery.
The goal is to determine which medication provides better hemodynamic stability and improves recovery in the early postoperative period.
The 3 groups in the trial
- Arm 1: Control Group (Normal Saline)Placebo, for comparison
Participants in this arm will receive 15 mL of 0.9% normal saline intravenously over 15 minutes, starting 30 minutes before the anticipated time of extubation. This serves as the control intervention for comparison with lidocaine and magnesium sulfate.
Treatment: Normal Saline (Intravenous)
- Arm 2: Lidocaine GroupTreatment being tested
Participants in this arm will receive intravenous lidocaine at a dose of 1.5 mg/kg diluted with 0.9% normal saline to a total volume of 15 mL. The infusion will be administered over 15 minutes, starting 30 minutes before the expected time of extubation.
Treatment: Lidocaine (drug)
- Arm 3: Magnesium Sulfate GroupTreatment being tested
Participants in this arm will receive intravenous magnesium sulfate at a dose of 30 mg/kg diluted with 0.9% normal saline to a total volume of 15 mL. The infusion will be administered over 15 minutes, starting 30 minutes before the anticipated time of extubation.
Treatment: magnesium sulfate
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intravenous Lidocaine Versus Magnesium Sulfate for Hemodynamic Stability During Emergence From General Anesthesia in Infertility-related Laparoscopic Gynecologic Surgeries
- Plain-language title
- Lidocaine or magnesium sulfate to keep blood pressure steady after infertility surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07359560, who can take part
- Record updated
- 22 January 2026